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Abstract
Despite of the recent advances in diagnostic and therapeutic approaches, cancer remains 
as the leading cause of death worldly with diverse causal factors regarding genes and 
environment. Invasion and metastasis, as one of the most important hallmarks for cancer, 
have restrained the successful clinical therapy and are the primary causes of death among 
cancer patients. So far, most chemotherapeutic drugs are not effective for metastatic can-
cer due to drug resistance and serious side effects. Therefore, it is urgently essential to 
develop more effective therapeutic methods. Owing to their diverse biological activities 
and low toxicity, naturally active compounds derived from Chinese medicines, as a com-
plementary and alternative approach, are reported to promote the therapeutic index and 
provoked as an excellent source for candidates of anti-metastatic drugs. With the rapid 
development of molecular biology techniques, the molecular mechanisms of the effects 
of potential anti-invasive and metastatic Chinese medicines are gradually elucidated. 
This chapter reviews the potential anti-invasive and metastatic mechanisms of naturally 
active compounds from Chinese medicines, including suppression of EMT, proteases 
and cancer-induced angiogenesis, anoikis regulation of circulating tumor cells and regu-
lation of miRNA-mediated gene expression, providing scientific evidence for clinically 
using Chinese medicines in the field of cancer therapy.
Keywords: Chinese medicines, anti-invasion and metastasis, molecular mechanisms, 
cancer therapy
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1. Introduction
Despite of all the recent advances in diagnostic and therapeutic approaches, cancer remains 
the leading cause of death and primary public health hazard all over the world [1, 2]. With 
diverse causal factors (genetic and environmental, physical, psychological and biochemical 
factors), cancer has a various disease spectrum to more than a hundred different kinds of 
malignancies, such as lung cancer, breast cancer, renal carcinoma, hepatocellular carcinoma, 
and so on [3]. It is a progressive disease with multiple pathological processes covering can-
cer initiation, development, and metastasis. Cancer is characterized by several key hallmarks 
[4–6], namely uncontrolled replication ability of abnormal cells, resistance to programmed 
cell death, invasion into the surrounding extracellular matrix (ECM), sustained capability of 
angiogenesis, and metastatic spread to other sites.
As one of the most important hallmarks for cancer, metastasis is an intricate process concern-
ing the following six steps (as shown in Figure 1): (i) detachment of cancer cells through 
degrading ECM, (ii) local migration and invasion into the surrounding tissues, (iii) intravasa-
tion into blood and/or lymphatic vessel systems, (iv) survival and circulation in the circula-
tory system, (v) extravasation into the targeted secondary organ site, and (vi) multiplication 
and formation of a secondary tumor [7–9]. During these steps, the metastatic cancer cells 
should have special properties to overcome the obstacles, such as the capability of invasion, 
resistance to anoikis, and angiogenesis. Basically, these steps are regulated by multiple fac-
tors, including but not limited to changes of expression of related genes, cytoskeleton remod-
eling, proteolysis degradation of ECM, and so on [10]. Metastasis is a nonrandom process, 
and different metastatic cancer types possess their corresponding preferred sites of metasta-
sis. For instance, the preferred sites of breast cancer cells are lung, liver, and bone [11]. Since 
invasion and metastasis restrain the successful clinical therapy and are the primary causes 
of death among cancer patients, it has been widely accepted that invasion and metastasis 
become a highlighted topic of research interests, and active efforts are still needed to under-
stand the underlying molecular mechanisms and develop effective anti-metastatic therapies.
At the present day, there are three conventional therapeutic approaches which are used to 
treat metastatic cancers, namely surgical resection, chemotherapy, and radiotherapy. Though 
remain as the main treatment approach for metastatic cancer patients, most chemotherapeutic 
drugs are not effective for metastatic cancer due to drug resistance and serious side effects. 
Most chemotherapeutic drugs fail to selectively kill cancer cells without destroying normal cells 
at the sites of metastasis [12] and thus cause severe toxicity, such as appetite loss, weight loss, 
insomnia, fatigue, even life threat etc [13, 14]. Although chemotherapeutics significantly leads to 
regression of the primary tumor, some investigations even report that it may also promote and 
enhance metastatic formation of a secondary tumor [15, 16]. Besides, metastatic cancers are dem-
onstrated to be largely resistant against chemotherapeutics. Despite that various approaches 
have been applied to treat metastatic cancers, the clinical outcomes of metastatic cancer treat-
ment are still not at a satisfactory level. Therefore, it is urgently essential to develop more effec-
tive therapeutic methods with minimal adverse effects for metastatic cancer treatment.
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Traditional medicine, such as Chinese medicine, has been shown to exhibit various phar-
macological activities and used in treatment of various diseases in Asian countries and 
regions for a long time [17]. The numerous natural compounds obtained from Chinese 
medicines chemically range from flavonoids and polyphenols to mineral salts, which have 
been reported to be an excellent source for anti-cancer agents [18]. Owing to their long- 
lasting efficacy, diversity in biological activities, and low toxicity, natural active products 
from Chinese medicines, including single compounds and various extracts, are being 
developed for treatment of metastatic cancer [19, 20]. In line with such a concept, sev-
eral natural active products from Chinese medicines have been currently investigated as 
a complementary and alternative approach, and their anti-metastatic properties have been 
focused to find newly discovered mechanisms with the hope to promote the therapeutic 
index of metastatic cancer.
With the rapid development of molecular biology techniques, the molecular mechanisms 
underlying the effects of potential anti-invasive and metastatic Chinese medicines are gradu-
ally elucidated. Understanding of the underlying molecular mechanisms may in turn lead to 
the discovery of novel anticancer drugs. In summary, this chapter reviews the anti-invasive 
and metastatic effect of natural active compounds from Chinese medicines and their molecu-
lar mechanisms. Tables 1 and 2 respectively summarized the potential underlying molecular 
mechanisms of single pure compounds and various extracts from Chinese medicines to sup-
press cancer invasion and metastasis.
Figure 1. The process involving in cancer metastasis.
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Single pure compound Cancer type Study type Mechanism of actions Ref. (PMID)
Arctigenin Breast cancer In vitro MCF-7 and 
MDA-MB-231 cells
Suppress MMP-9 and 
uPA
28035371
Colorectal cancer In vitro CT26, 
MC38, CCD-18Co 
and SW620 cells 
and in vivo BALB/c 
female mice
Induce anoikis via 
MAPKs signaling, 
inhibit EMT through 
increasing E-cadherin 
and decreasing 
N-cadherin, vimentin, 
β-catenin, and Snail and 
downregulate MMP-2/9
27618887
Astragaloside IV Breast cancer In vitro 
MDA-MB-231 cells 
and in vivo athymic 
Balb/c nude mice
Downregulate Vav3 and 
MMP-2/9
27930970
Berberine Hepatocellular 
carcinoma
In vitro MHCC-
97L, Bel-7402, 
SMMC-7721 cells 
and in vivo nude 
mice
Downregulate uPA and 
suppress Id-1 via HIF-1α/
VEGF pathway
27092498
25496992
Nasopharyngeal 
carcinoma
In vitro HONE1 
cells
Suppress Rho GTPases 
including RhoA, Cdc42, 
and Rac1
19513545
Notoginsenoside R1 Colorectal cancer In vitro HCT-116 
cells
Reduce MMP-9, 
integrin-1, E-selectin and 
ICAM-1 expressions
27840961
Matrine Prostate cancer In vitro DU145 
and PC-3 and 
male Balb/c nude 
mice inoculated 
subcutaneously 
with cells
Downregulate MMP-2/9 28000853
Bibenzyl 
4,5,4′-trihydroxy-3,3′- 
dimethoxybibenzyl
Lung cancer In vitro H292 cells Suppress EMT markers 
(vimentin and Snail) 
and increase the level of 
E-cadherin and induce 
anoikis by reduction 
of activated protein 
kinase B (p-AKT) and 
activated extracellular 
signal-regulated kinase 
(p-ERK)
24692728
Curcumin Lung cancer In vitro H460 cells Sensitize anoikis by 
down-regulating Bcl-2
20127174
Imperatorin Lung cancer In vitro H23, H292 
and A549 cells
Sensitize anoikis by 
down-regulating 
Mcl-1 protein and 
up-regulating Bax
23108812
Artonin E Lung cancer In vitro H460, A549 
and H292 cells
Sensitize anoikis by 
down-regulating Mcl-1 
protein
23225436
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Single pure compound Cancer type Study type Mechanism of actions Ref. (PMID)
Ecteinascidin 770 Lung cancer In vitro H23 and 
H460 cells
Sensitize anoikis by 
down-regulating 
Mcl-1 protein and 
up-regulating Bax
23393342
Renieramycin M Lung cancer In vitro H460 cells Sensitize anoikis by 
down-regulating 
survival proteins p-ERK 
and p-AKT and anti-
apoptotic proteins BCL2 
and MCL1
27069144
Oroxylin A Lung cancer In vitro A549 cells 
and in vivo nude 
mice
Sensitize anoikis by 
inactivating the c-Src/
AKT/HK II pathway
23500080
Geraniin Lung cancer In vitro A549 cells Inhibit the TGF-β1-
induced EMT
26169124
Genipin Hepatocellular 
carcinoma
In vitro HepG2 and 
MHCC97L cells and 
in vivo male nude 
mice
Overexpress TIMP-1 and 
inhibit MMP-2
23029478
Kukoamine A Glioblastoma In vitro C6, U251 
and WJ1 cells and 
in vivo nude mice 
(BALB/C-nu/nu)
Inhibit EMT and 
induce anoikis by 
downregulating 
expressions of C/EBPβ 
and 5-LOX
27824118
Gigantol Lung cancer In vitro H460 cells Decrease EMT markers 
including N-cadherin, 
vimentin, and Slug
26733180
Moscatilin Lung cancer In vitro H460 cells Inhibit EMT by 
suppressing mesenchymal 
cell markers (vimentin, 
Slug, and Snail) and 
induce anoikis by survival 
proteins (ERK and Akt) 
suppression and Cav-1 
down-regulation
26384689
2,3,5- Trimethoxy-4-cresol Lung cancer In vitro A549 cells Suppress Akt, MMP-2 
and MMP-9 and increase 
E-cadherin and TIMP-1
25951809
Deoxyelephantopin Lung cancer In vitro A549 cells Suppress MMP-2, MMP-9, 
uPA, and uPAR
25686703
Bufalin Lung cancer In vitro NCI-H460 
cells
Suppress MMP-2, MMP-9, 
MAPKs, and NF-kB
26446205
Epicatechin-3-gallate Lung cancer In vitro A549 cells 
and in vivo BALB/c 
nude mice
Inhibit the TGF-β1-
induced EMT by 
up-regulating epithelial 
marker (E-cadherin) 
and down-regulating 
mesenchymal markers 
(fibronectin and p-FAK)
27224248
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Single pure compound Cancer type Study type Mechanism of actions Ref. (PMID)
Rocaglamide-A Prostate cancer, 
breast cancer and 
cervical cancer
In vitro PC-3, 
MDA- MB-231, 
HCT116, HeLa, and 
293T cells
Inhibit the activity of Rho 
GTPases RhoA, Rac1 and 
Cdc42
27340868
Chamaejasmenin B Breast cancer In vitro 
MDA-MB-231, 
ZR75-1 and 4T1 
cells and in vivo 
BALB/c mice
Block TGF-beta induced 
EMT
27374079
Artesunate Cervical cancer In vitro CaSki and 
Hela cells
Inhibit HOTAIR and 
COX-2 expressions
27736969
Ginsenoside Rd Breast cancer In vitro 4T1 cells 
and in vivo BALB/c 
mice
Derepress miR-18a-
mediated Smad2 
expression
27641158
Quercetin Colorectal cancer In vitro CT26 and 
MC38 cells and in 
vivo BALB/c female 
mice
Induce apoptosis 
through the MAPKs 
pathway, regulate EMT 
markers including E-, 
N-cadherin, β-catenin, 
and snail and regulate 
MMPs and TIMPs
27823633
Sulforaphane Lung cancer In vitro H1299, 95C 
and 95D cells and in 
vivo male BALB/c 
nude mice
Inhibit EMT by silencing 
miR-616-5p
27890917
Tricetin Osteosarcoma In vitro U2OS and 
HOS cells
Repress MMP-9 via p38 
and Akt pathways
27860196
Arsenic trioxide Chondrosarcoma In vitro HCS-2/8, 
OUMS-27, SW1353, 
and JJ012 cells
Inhibit EMT via the miR-
125b/Stat3 axis
27576314
Cucurbitacin B Breast cancer In vitro 
MDA-MB-231 and 
4T1 cells
Inhibit angiogenesis via 
downregulating VEGF/
FAK/MMP-9 signaling
27210504
2,3,5,4′-Tetrahydroxystilbene-
2-O-β-D-glucoside
Colorectal cancer In vitro HT-29 cells Suppress MMP-2 and 
ICAM-1 via NF-κB 
pathway
27278328
7,7″-Dimethoxyagastisflavone Melanoma In vitro B16F10 cells 
and in vivo female 
C57BL/6JNarl mice
Down-regulate the 
polymerization of 
F-actin via Cdc42/Rac1 
pathway and inhibit 
lamellipodia formation 
via suppressing CREB 
phosphorylation
27487150
Nobiletin Osteosarcoma In vitro U2OS and 
HOS cells
Block ERK and JNK-
mediated MMPs 
expression
27144433
Table 1. Summary on the potential underlying molecular mechanisms of single pure compound from Chinese medicines 
to suppress cancer invasion and metastasis.
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2. Suppression of epithelial-mesenchymal transition
Recent studies clearly showed that epithelial-mesenchymal transition (EMT) plays an important 
role in the metastasis of cancers [21]. As the fundamental step during cancer metastasis, EMT 
is a complex process during which immotile epithelial cells undergo a morphological transfor-
mation into motile mesenchymal-appeared cells, triggering cancer cells to detach from the pri-
mary site via the loss of cell-to-cell junctions and thus promoting cell migration [22]. There are 
Various extracts Cancer type Study type Mechanism of actions Ref. (PMID)
Ethanol extract of baked 
Gardeniae Fructus
Melanoma In vitro B16F10 and in vivo 
C57BL/6 mice
Inhibiting the release of 
pro-angiogenic factors 
from tumor cells
27779658
Mixture of flavonoids 
extracted from Korean 
Citrus aurantium
Lung cancer In vitro A549 cells and in 
vivo NOD/SCID mice
Induce apoptosis through 
regulating the apoptosis 
related protein cleaved 
caspase-3 and p-p53
No
Bibenzyl compounds 
isolated from 
Dendrobium pulchellum
Lung cancer In vitro Induce anoikis 23472473
Aqueous extract of 
Andrographis paniculata
Esophageal 
cancer
In vitro EC-109 and KYSE-
520 cells
Inhibit anoikis resistance 26885447
Methanol extracts of 
Euphorbia humifusa Willd
Breast cancer In vitro MDA-MB-231 and 
in vivo Balb/c mice
Reduce TNFα-induced 
MMP-9 expression
27776550
Ethanol extract of 
Lophatheri Herba
Fibrosarcoma, 
breast cancer, 
prostate carcinoma 
and melanoma
In vitro HT1080, 
MDA-MB231, DU145, 
B16F10 cells and in vivo 
C57BL/6J mice and ICR mice
Suppress tumor-
induced angiogenesis 
by decreasing the pro-
angiogenic factors
27808120
Coptidis Rhizoma 
aqueous extract
Hepatocellular 
carcinoma
In vitro Hep G2 and 
MHCC97-L cells and in vivo 
nude mice
Suppress Rho/ROCK 
signaling pathway and 
inhibit VEGF secretion
21106616
24363282
Methanol extracts and 
butanol extracts of 
Oldenlandia diffusa
Breast cancer In vitro MCF-7 cells Inhibit PMA-induced 
MMP-9 and ICAM-1 
expressions
27876502
Annona muricata leaf 
aqueous extract
Breast cancer In vitro 4 T1 cells and in 
vivo female BALB/c mice
Induce the apoptosis 27558166
Ethanol extract of 
Siegesbeckia orientalis
Endometrial 
Cancer
In vitro RL95-2 and HEC-1A Reverse the TGFβ1-
induced EMT
27527140
Polyphenols of Artemisia 
annua L.
Breast cancer In vitro MDA-MB-231 cells Suppress EMT by 
inhibiting MMP-2/-9 and 
vascular cell adhesion 
molecule-1
27151203
Gegen Qinlian decoction Renal carcinoma In vitro ACHN and Caki-1 
cells and in vivo male 
BALB/c nude mice
Suppress 
neoangiogenesis via 
MMP-2 inhibition
25228536
Table 2. Summary on the potential underlying molecular mechanisms of various extracts from Chinese medicines to 
suppress cancer invasion and metastasis.
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three  different subtypes of EMT, and the third subtype of EMT is associated with the invasion 
and metastasis of cancers [23]. EMT-phenotypic cells can decrease the level of epithelial marker 
E-cadherin, a junction protein for cell-cell contact. Besides, they can also increase the level of mes-
enchymal markers, such as N-cadherin, β-catenin, and vimentin, as well as promote transcription 
factors of EMT switch, such as Slug and Snail [24, 25]. As EMT has been significantly linked to the 
metastatic behaviors of cancer cells, natural products obtained from Chinese medicines with the 
ability to suppress EMT are attracting attention for the development of anti-metastasis therapies.
Among potential natural products, geraniin, a polyphenolic component derived from 
Phyllanthus amarus, has gained considerable attention over the past decade. Previous study 
has demonstrated that EMT can be induced by transforming growth factor-beta 1 (TGF-β1) 
and thus stimulates the migration and invasion of lung adenocarcinoma. Geraniin has been 
shown to inhibit TGF-β1-induced EMT of lung cancer A549 cells in vitro by inducing the 
epithelial marker E-cadherin and suppressing Snail and mesenchymal marker N-cadherin 
and vimentin [26]. A compound derived from Dendrobium ellipsophyllum, bibenzyl 4,5,4′ 
-trihydroxy-3,3′-dimethoxybibenzyl was shown to inhibit EMT of lung cancer cells via down-
regulating EMT markers (vimentin and Snail) and upregulating E-cadherin [27]. Such EMT 
suppression was also observed in lung cancer cells treated with other single compounds 
obtained from Chinese medicine, such as moscatilin [28], gigantol [29], and epicatechin-3- 
gallate [30]. A flavonoid obtained from Stellera chamaejasme L., namely chamaejasmenin B, 
was also reported to block the TGF-β-induced EMT in breast cancer [31]. 5-lipoxygenase 
(5-LOX) is an enzyme to convert arachidonic acid to leukotrienes [32] and abrogating its 
expression can inhibit the migration, invasion, and metastasis of cancer cells by suppressing 
EMT via inactivating E-cadherin and activating snail [33]. CCAAT/enhancer binding protein 
β (C/EBPβ) was also reported to be related to the migration, invasion, and metastasis of can-
cer cells by EMT regulation [34]. Kukoamine A, a spermine alkaloid extracted from Cortex 
lycii radicis, was demonstrated to suppress the migratory and invasive ability of human 
glioblastoma cell both in vitro and in vivo, and this action was mediated through EMT atten-
uation via decreasing the levels of 5-LOX and C/EBPβ [35]. Likewise, similar EMT inhibitory 
effects have also been observed in various extracts from Chinese medicines. Siegesbeckia ori-
entalis Linne is a traditionally used Chinese medicinal herb that exhibits various pharmaco-
logical activities. Its ethanol extract (SOE) has been reported as a potential anti-metastatic 
agent by reversing the TGFβ1-induced EMT via ERK1/2, JNK1/2, and Akt pathways [36]. 
SOE can inhibit the migration and invasion of endometrial cancer RL95-2 and HEC-1A cells 
in a dose-dependent manner. Artemisia annua L. is a traditional medicine which has been 
applied for treating multiple diseases. The polyphenolic compounds from Artemisia annua 
L. (pKAL) were found to exhibit anti-metastatic property on highly metastatic breast cancer 
cells MDA-MB-231 [37]. This anti-metastatic property of pKAL was achieved through sup-
pressing EMT by inhibiting MMP-2/-9 and vascular cell adhesion molecule-1 (VCAM-1).
3. Suppression of proteases expression
Matrix metalloproteinases (MMPs) is regarded as primary factors to trigger metastasis [38]. 
As extracellular zinc-dependent endopeptidases, they can degrade the basement membrane 
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and ECM and thus play an important role in the migration and invasion of cancers. There are 
23 members in MMPs family, among which MMP-2 and MMP-9 are considered to be the key 
enzymes and play crucial roles in cancer metastasis [39, 40]. The activities of MMPs are finely 
mediated by tissue inhibitors of metalloproteinases (TIMPs) via their non-covalent binding 
to the active zinc-binding sites of MMPs [41]. In addition, as a serine-specific protease, uro-
kinase-type plasminogen activator (uPA) can also degrade ECM via binding to uPA receptor 
(uPAR) and activating plasmin [42]. It is well-known that reorganization of the actin cyto-
skeleton plays an important role in the migration of cancer cell [43]. This process is mainly 
regulated by the Rho family GTPases, such as RhoA, Rac1, and Cdc42 via a shuttle between an 
inactive GDP-bound form and an active GTP-bound form [44, 45]. Since these proteases play 
an important role in cancer invasion and metastasis via proteolysis, natural products obtained 
from Chinese medicines with the ability to suppress these proteases are attracting attention 
for the development of anti-metastasis therapies.
As a phytoestrogen-botanical lignan derived from Arctium lappa, arctigenin was shown to 
exert its anti-metastatic property through suppressing MMP-9 and uPA of breast cancer cells 
via inhibiting the upstream signaling pathways including Akt, NF-κB, and MAPK (ERK 1/2 
and JNK 1/2), which is dependent to the modulation on estrogen receptor (ER) expression [46]. 
Such protease regulation was also observed in breast cancer cells treated with astragaloside IV 
[47]. Notoginsenoside R1 (NGR1) is a primary compound in Panax notoginseng, and its anti-
metastatic property has also been revealed [48]. NGR1 can inhibit the migration, invasion, 
and adhesion of cultured human colorectal cancer cells (HCT-116) via suppressing MMP-9, 
integrin-1, E-selectin, and ICAM-1 expressions. Such inhibition on colorectal cancer cells was 
also observed when treated with 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside [49]. As an 
alkaloid derived from Sophora flavescens, matrine can inhibit the invasion and migration of 
castration-resistant prostate cancer DU145 and PC3 cells by suppressing MMP-9 and MMP-2 
expressions through NF-κB pathway [50]. The phenol derived from Taiwanese edible fungus 
Antrodia cinnamomea, 2,3,5-trimethoxy-4-cresol, was recently described as an effective anti-
metastatic agent against lung cancer via suppressing Akt, MMP-2 and MMP-9, and increasing 
E-cadherin and TIMP-1[51]. Such protease regulation was also observed in lung cancer cells 
treated with other single compounds derived from Chinese medicine, such as deoxyelephan-
topin [52] and bufalin [53]. Genipin, a natural compound obtained from the fruit of Gardenia 
jasminoides, was reported to exhibit anti-metastatic effect on hepatocellular carcinoma both 
in cell and animal model. This effect may be related with TIMP-1 overexpression and MMP-2 
inhibition of genipin [54]. As an isoquinoline alkaloid isolated from Coptidis rhizome and 
other medicinal plants, berberine has been shown to exhibit multiple pharmacological actions 
in treating human diseases, including cancers [55]. Recently, it was reported to inhibit naso-
pharyngeal carcinoma cell migration and invasion in vitro through suppressing Rho GTPases 
including RhoA, Rac1, and Cdc42 [56]. The anti-metastatic ability of Rocaglamide-A was also 
recently described via inhibiting the activity of Rho GTPases RhoA, Rac1, and Cdc42 [57]. As 
a dietary flavonoid in Eucalyptus honey and Myrtaceae pollen, tricetin was shown to attenu-
ate osteosarcoma cell migration via suppressing MMP-9 via p38 and Akt pathways [58]. Such 
inhibition on osteosarcoma cells was also observed when treated with nobiletin [59]. The com-
pound obtained from Taxus x media cv. Hicksii, 7,7″-Dimethoxyagastisflavone (DMGF) has 
been reported to inhibit the invasion and metastasis of melanoma cells in vivo and in vitro 
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[60]. The mechanism study provided evidence that DMGF can downregulate the polymeriza-
tion of F-actin via Cdc42/Rac1 pathway and inhibit lamellipodia formation via suppressing 
cAMP response element-binding protein (CREB) phosphorylation. Likewise, similar protease 
inhibitory effects have also been observed in various extracts from Chinese medicines. The 
methanol extracts of Euphorbia humifusa Willd was reported to have anti-metastatic effects on 
breast cancer both in vitro and in vivo via reducing TNFα-induced MMP-9 expression [61]. 
In addition, the methanol extracts and butanol extracts of Oldenlandia diffusa were also shown 
to block the metastasis of breast cancer via inhibiting PMA-induced MMP-9 and ICAM-1 
expressions [62].
4. Suppression of cancer-induced angiogenesis
Angiogenesis is a normal physiological process to sprout new vessels during the  development 
of embryogenesis. To the contrary, pathological angiogenesis is associated with multiple 
 diseases including cancers [63]. Highly malignant tumors can induce angiogenesis to provide 
sufficient oxygen and nutrients for themselves [64]. Additionally, angiogenesis also provides 
paths for cancer cells to metastasize distant tissues [65]. In tumor microenvironment, tumor 
and host cells release pro-angiogenic and anti-angiogenic factors. The pro-angiogenic factors 
include transforming growth factor (TGF), vascular endothelial growth factor (VEGF), tumor 
necrosis factor (TNF), epidermal growth factor (EGF), and so on, and there is a fine balance 
between them. When the balance is skewed to the pro-angiogenic state, tumor shifts from a 
dormant state to a hyper-vascularized state [66]. Since angiogenesis plays an important role 
in the metastatic behaviors of cancer cells, natural products obtained from Chinese medi-
cines targeting on tumor-induced angiogenesis have been regarded as promising agents to 
 metastatic cancers.
Berberine has been shown to exhibit a significant inhibition on the migratory and invasive 
ability of hepatocellular carcinoma cells. Except for downregulation of uPA, berberine also 
inhibits angiogenesis through suppressing inhibitor of differentiation/DNA binding (Id-1) 
via HIF-1α/VEGF pathway [67, 68]. Cucurbitacin B (CuB), a plant triterpenoid, obtained 
from Cucurbitaceae family has been shown to inhibit the metastasis and angiogenesis of 
breast cancer MDA-MB-231 and 4T1 cells via downregulating VEGF/FAK/MMP-9 signaling 
[69]. Recently, a study of artesunate, a normal traditional Chinese medicine, has been con-
ducted to investigate the anti-metastatic effects of artesunate on cervical cancer. The results 
 demonstrated that artesunate inhibits cancer cell migration and invasion in vitro through sup-
pressing HOTAIR and COX-2-mediated angiogenesis [70]. Likewise, similar inhibitory effects 
have also been observed in various extracts from Chinese medicines. The aqueous extract of 
Coptidis Rhizoma, a traditional Chinese medicinal herb with a long history, was observed to 
inhibit hepatocellular carcinoma cell migration both in vitro and in vivo through suppressing 
Rho/ROCK signaling pathway and inhibiting VEGF secretion [71, 72]. Gardeniae Fructus, a 
fruit obtained from Gardenia jasminoides Ellis, has been applied as traditional medicine and 
possesses various health benefits against multiple diseases. A recent study has shown that 
the ethanol extract of baked Gardeniae Fructus has an inhibitory effect on the angiogenic 
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and metastatic ability of melanoma cells both in vitro and in vivo via inhibiting the release 
of pro-angiogenic factors [73]. Lophatheri Herba, a dried leaf obtained from Lophatherum 
gracile Brongn, possesses inhibitory effects on the metastasis and angiogenesis of malignant 
cancer cells at noncytotoxic doses. It has been shown that ethanol extract of Lophatheri Herba 
(ELH) can inhibit the cancer cell metastasis both in vitro and in vivo through suppressing 
tumor-induced angiogenesis via decreasing the pro-angiogenic factors [74]. As an ancient 
Chinese medicine formula, Gegen Qinlian decoction was reported to suppress the neoangio-
genesis in xenografted renal carcinoma cell tumor through inhibiting the enzyme activity of 
MMP-2 [75].
5. Anoikis regulation of circulating tumor cells
Anoikis, known as detachment-induced apoptosis, is a process of programmed cell death [76]. 
It can block metastasis by eliminating circulating cancer cells. However, in highly  metastatic 
cancer cells, anoikis can be overcome and cancer cells can survive in a circulating condition until 
reaching a proper secondary site [77]. Anoikis is controlled by Bcl-2 family proteins. The pro-
apoptotic proteins, such as Bax and the anti-apoptotic proteins, such as Bcl-2 and Bcl-xL, inter-
act during anoikis [78]. In addition, anti-apoptotic protein myeloid leukemia cell sequence-1 
(MCL-1) and caveolin-1 (CAV-1) have also been demonstrated to suppress anoikis [79]. Anoikis 
has become potential therapeutic target, and discovering new natural products obtained from 
Chinese medicines targeting anoikis is of great interest [80].
The anti-metastatic study of arctigenin on colorectal cancer has been recently conducted. 
Arctigenin can induce anoikis via MAPKs signaling, inhibit EMT through increasing 
E-cadherin and decreasing N-cadherin, vimentin, β-catenin, and Snail, and downregulate 
MMP-2/9, so that inhibition on the tumor cell migration and invasion both in vitro and in 
vivo was achieved [81]. Imperatorin, an active furanocoumarin component obtained from the 
root of Angelica dahurica, has been demonstrated to sensitize anoikis by downregulating Mcl-1 
protein and upregulating Bax in lung cancer [82]. As a major dietary flavonoid, quercetin was 
reported to induce apoptosis through the MAPKs pathway, regulate EMT markers includ-
ing E-, N-cadherin, β-catenin, and snail and modulate MMPs and TIMPs in colorectal cancer 
[83]. Curcumin, a compound derived from the rhizome of turmeric, was reported to inhibit 
the migratory and invasive ability of lung cancer cells through sensitizing anoikis, which 
was associated with downregulation of Bcl-2 [84]. Such anoikis regulation was also observed 
in lung cancer cells challenged other single compounds obtained from Chinese medicine, 
such as artonin E [85], ecteinascidin 770 [86], renieramycin M [87], Oroxylin A [88], and so 
on. In addition, regulation on anoikis was also observed in tumor cells treated with various 
extracts from Chinese medicines. Annona muricata Linn from Annonaceae family has long 
been applied to treat different diseases. Recently, its leaf aqueous extract (B1 AMCE) has 
been reported to exhibit anti-metastatic property in breast cancer [89]. B1 AMCE can signifi-
cantly suppress the metastasis of 4T1 breast cancer cells in vitro and in vivo via inducing their 
apoptosis. The aqueous extract of Andrographis paniculata was demonstrated to inhibit anoikis 
resistance in esophageal cancer [89]. The bibenzyl compounds from Dendrobium pulchellum 
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[90] and the mixture of flavonoids extracted from Korean Citrus aurantium have been shown 
to induce apoptosis and inhibit metastasis of lung cancer cells [91].
6. Regulation of miRNA-mediated gene expression
As negative regulators of gene expression, microRNAs (miRNAs) have been shown to modu-
late multiple biological functions, such as immune response, metabolism, and metastasis [92]. 
miRNAs mediate the expression of target protein through degrading its mRNA or inhibit-
ing the translation of mRNA via binding to mRNA three prime untranslated region (3′UTR). 
There is a dual action of miRNAs in cancers, either functioning as cancer promoters or inhibi-
tors. Nearly, all human tumors have the characteristic of miRNAs dysregulation [93]. Since 
miRNAs play an important role in the metastatic behaviors of cancer cells, developing natural 
products obtained from Chinese medicines targeting miRNAs may be a promising strategy 
to treat metastatic cancers.
Recently, the anti-metastatic property of arsenic trioxide (ATO) in chondrosarcoma has 
been elucidated. It was reported that ATO attenuate the metastasis of chondrosarcoma cells 
through inhibit miR-125b/Stat3 axis [94]. As a common antioxidant obtained from cruciferous 
plants, sulforaphane has been reported to inhibit the migratory and invasive ability of lung 
cancer both in vitro and in vivo. This action is mediated by miR-616-5p [95]. In addition, gin-
senoside Rd (Rd), one of the chemical compounds in Panax Notoginseng Saponins, has been 
investigated for its anti-metastatic property recently. The results showed that Rd treatment 
inhibited the migratory and invasive ability of breast cancer both in vitro and in vivo via sup-
pressing miR-18a-mediated Smad2 expression [96].
7. Conclusion and future challenges
Accumulating evidence has demonstrated that Chinese medicine is an excellent source for 
the development of novel therapies for metastatic cancer. As mentioned above, the molecular 
mechanisms underlying the effects of potential anti-invasive and metastatic Chinese medi-
cines include suppression of EMT (e.g., epithelial and mesenchymal markers), suppression 
of proteases expression (e.g., MMPs, uPA and Rho GTPases), suppression of cancer-induced 
angiogenesis (e.g., pro-angiogenic and anti-angiogenic factors), anoikis regulation of circulat-
ing tumor cells (e.g., pro-apoptotic and anti-apoptotic proteins), and regulation of miRNA-
mediated gene expression (e.g., miR-125b, miR-616-5p and miR-18a). The chapter summarized 
the potential anti-invasive and metastatic drug candidates, which provided scientific evi-
dence for clinically used Chinese medicines in the field of cancer therapy. Understanding 
of the underlying molecular mechanisms may in turn lead to discovery and development of 
novel anticancer drugs. Although these findings show the anti-metastatic potential of Chinese 
medicines, studies to evaluating the marked efficacies and determining the appropriate thera-
peutic doses of anti-metastatic Chinese medicines in animal models and clinical trials are still 
Unique Aspects of Anti-cancer Drug Development126
badly necessary in the future. In addition, the modern techniques such as nanoparticles which 
may improve the anti-cancer properties via better cellular uptake, enhanced bioavailability, 
and localization to targeted sites should also be studied in the future.
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